Using mouse models of T1 and T2D, it was demonstrated that inhibiting NLRP-3 inflammasome activation reduces renal inflammation and fibrosis, partly by suppressing oxidative stress in DKD [174]. Here, NLRP3 is linked to diabetic kidney disease.